Gentex Corp. (GNTX) financial statements: income statement, balance sheet and cash flow
Gentex Corp.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Gentex Corp. reported revenue of $2.5B (+9.6% year on year) and net income of $384.8M.
Income statement
Gentex Corp. income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
NET SALES
$2.5B
$2.3B
$2.3B
$1.9B
COST OF GOODS SOLD
$1.7B
$1.5B
$1.5B
$1.3B
Gross profit
$866.7M
$771.1M
$762.6M
$609.8M
Engineering, research and development
$203.3M
$181.5M
$154.4M
$133.3M
Selling, general and administrative
$177.9M
$121.0M
$112.5M
$106.5M
Severance expense
$11.6M
—
—
—
Impairment Charges
$0
$8.9M
—
—
Total operating expenses
$392.8M
$311.4M
$266.9M
$239.8M
Income from operations
$473.9M
$459.7M
$495.7M
$370.0M
Investment (loss) income, net
($1.3M)
—
—
—
Other, net
($11.6M)
($915.7K)
($4.2M)
($5.1M)
Total other (loss) income
($12.9M)
$12.5M
$9.3M
($283.1K)
Income before provision for income taxes
$461.1M
$472.2M
$505.0M
$369.7M
PROVISION FOR INCOME TAXES
$76.4M
$67.7M
$76.6M
$51.0M
NET INCOME
$384.7M
$404.5M
—
—
Less: Net loss attributable to non-controlling interests
($159.3K)
—
—
—
NET INCOME ATTRIBUTABLE TO GENTEX CORPORATION
$384.8M
—
$428.4M
$318.8M
Basic (in dollars per share)
$1.74
$1.77
$1.84
$1.36
Diluted (in dollars per share)
$1.74
$1.76
$1.84
$1.36
Cash Dividends Declared per Share (in dollars per share)
$0.48
$0.48
$0.48
$0.48
Gentex Corp. income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
NET SALES
$651.3M
$675.4M
$655.2M
$657.9M
COST OF GOODS SOLD
$410.3M
$446.8M
$430.1M
$432.6M
Gross profit
$241.0M
$228.6M
$225.2M
$225.3M
Engineering, research and development
$49.3M
$51.7M
$52.6M
$51.5M
Selling, general & administrative
$50.0M
$49.8M
$49.7M
$48.5M
Impairment charges (Note 3)
$0
$2.8M
—
—
Severance expense
$362.9K
$722.5K
$518.2K
$6.8M
Total operating expenses
$99.7M
$105.0M
$102.8M
$106.8M
Income from operations
$141.3M
$123.7M
$122.3M
$118.5M
Investment (loss) income, net
($5.6M)
($87.4K)
$542.1K
($3.6M)
Other, net
$1.1M
($5.5M)
($2.3M)
$578.2K
Total other (loss) income, net
($4.5M)
($5.6M)
($1.8M)
($3.0M)
INCOME BEFORE PROVISION FOR INCOME TAXES
$136.8M
$118.0M
$120.6M
$115.5M
PROVISION FOR INCOME TAXES
$22.6M
$19.6M
$19.7M
$19.8M
NET INCOME
$114.2M
$98.4M
$100.9M
$95.7M
Less: Net loss attributable to non-controlling interests
($505.6K)
($34.1K)
($81.2K)
($389.1K)
NET INCOME ATTRIBUTABLE TO GENTEX CORPORATION
$114.7M
$98.5M
$101.0M
$96.0M
Basic (in dollars per share)
$0.54
$0.46
$0.46
$0.43
Diluted (in dollars per share)
$0.54
$0.46
$0.46
$0.43
Cash Dividends Declared per Share (in dollars per share)
$0.12
$0.12
$0.12
$0.12
Balance sheet
Gentex Corp. balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$145.6M
$233.3M
$226.4M
$214.8M
Short-term investments
$5.4M
$22.3M
$14.4M
$23.0M
Accounts receivable, net
$368.5M
$295.3M
$321.8M
$276.5M
Inventories, net
$516.3M
$436.5M
$402.5M
$404.4M
Prepaid expenses and other
$92.6M
$49.9M
$32.7M
$26.0M
Total current assets
$1.1B
$1.0B
$997.7M
$948.7M
Land, buildings and improvements
$591.5M
$531.3M
$472.1M
$376.9M
Machinery and equipment
$1.2B
$1.1B
$1.0B
$935.8M
Construction-in-process
$83.0M
$177.9M
$158.3M
$165.6M
Total Plant and Equipment
$1.9B
$1.8B
$1.6B
$1.5B
Less- Accumulated depreciation
($1.1B)
($1.0B)
($989.5M)
($928.3M)
Net Plant and Equipment
$790.9M
$728.5M
$652.9M
$550.0M
Goodwill
$357.2M
$340.7M
$340.1M
$313.8M
Long-term investments
$273.0M
$339.6M
$299.1M
$153.9M
Intangible assets, net
$189.3M
$195.2M
$214.0M
$219.4M
Deferred tax asset
$108.3M
$53.2M
$41.1M
$25.5M
Patents and other assets, net
$81.4M
$66.4M
$66.5M
$67.5M
Total Other Assets
$1.0B
$995.0M
$960.8M
$828.5M
TOTAL ASSETS
$2.9B
$2.8B
$2.6B
$2.3B
Accounts payable
$249.0M
$168.3M
$184.4M
$151.7M
Salaries, wages and vacation
$23.2M
$19.5M
$22.7M
$17.5M
Income taxes
$847.0K
$439.5K
$693.4K
$18.7M
Royalties
$29.4M
$21.1M
$20.9M
$19.2M
Dividends payable
$25.9M
$27.3M
$27.8M
$28.1M
Short-term debt
$3.8M
—
—
—
Other
$55.5M
$16.1M
$15.1M
$15.3M
Total current liabilities
$387.5M
$252.7M
$271.6M
$250.6M
OTHER NON-CURRENT LIABILITIES
$49.2M
$36.0M
$27.3M
$10.9M
DEFERRED INCOME TAXES
$908.9K
—
—
—
TOTAL LIABILITIES
$437.7M
$288.7M
$298.9M
$261.4M
REDEEMABLE NON-CONTROLLING INTEREST
$3.1M
—
—
—
Common stock, par value 0.06 per share; 400,000,000 shares authorized; 215,445,024 and 227,207,472 shares issued and outstanding in 2025 and 2024, respectively.
$12926701.00
$13632448.00
$13887326.00
$14050160.00
Additional paid-in capital
$1.0B
$1.0B
$968.2M
$917.5M
Retained earnings
$1.5B
$1.5B
$1.3B
$1.1B
Unrealized income (loss) on investments, net
$1.3M
($591.6K)
($2.0M)
($10.1M)
Unrealized loss on derivatives
($769.0K)
—
—
—
Cumulative translation adjustment
($310.3K)
($5.8M)
($4.5M)
($4.0M)
TOTAL GENTEX CORPORATION SHAREHOLDERS' INVESTMENT
$2.5B
$2.5B
$2.3B
$2.1B
Non-controlling Interest
$0
$4.1M
—
—
TOTAL SHAREHOLDERS' INVESTMENT
$2.5B
—
—
—
TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND SHAREHOLDERS' INVESTMENT
$2.9B
$2.8B
$2.6B
$2.3B
Gentex Corp. balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$233.4M
$164.8M
$178.6M
$119.8M
Short-term investments
$9.4M
$10.3M
$4.8M
$21.3M
Accounts receivable, net
$386.3M
$419.5M
$384.7M
$373.0M
Inventories, net
$519.0M
$523.5M
$499.2M
$475.7M
Prepaid expenses and other
$82.8M
$90.2M
$101.2M
$72.2M
Total current assets
$1.2B
$1.2B
$1.2B
$1.1B
PLANT AND EQUIPMENT—NET
$780.2M
$786.3M
$799.5M
$783.9M
Goodwill
$360.8M
$360.9M
$356.9M
$340.7M
Long-term investments
$238.5M
$270.1M
$247.4M
$267.0M
Intangible assets, net
$184.6M
$185.6M
$191.4M
$186.6M
Deferred tax asset
$112.6M
$109.4M
$92.7M
$90.7M
Patents and other assets, net
$91.7M
$77.0M
$82.4M
$83.0M
Total other assets
$988.3M
$1.0B
$970.8M
$968.0M
TOTAL ASSETS
$3.0B
$3.0B
$2.9B
$2.8B
Accounts payable
$248.3M
$276.6M
$252.0M
$204.7M
Short-term debt
$3.7M
$3.8M
$4.1M
$3.9M
Accrued liabilities
$153.1M
$164.1M
$138.3M
$128.3M
Total current liabilities
$405.1M
$444.6M
$394.5M
$336.9M
OTHER NON-CURRENT LIABILITIES
$52.5M
$46.5M
$45.1M
$43.8M
DEFERRED INCOME TAXES
$909.6K
$940.1K
$1.7M
—
TOTAL LIABILITIES
$458.5M
$492.0M
$441.2M
$380.7M
REDEEMABLE NON-CONTROLLING INTEREST
$2.8M
$3.0M
$2.3M
$2.5M
Common stock
$12.6M
$12.8M
$13.1M
$13.2M
Additional paid-in capital
$1.0B
$1.0B
$1.0B
$998.9M
Retained earnings
$1.5B
$1.5B
$1.5B
$1.4B
Accumulated other comprehensive income
$1.7M
$1.2M
($2.6M)
($3.4M)
TOTAL SHAREHOLDERS' INVESTMENT
$2.5B
$2.5B
$2.5B
$2.4B
TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND SHAREHOLDERS' INVESTMENT
$3.0B
$3.0B
$2.9B
$2.8B
Cash flow statement
Gentex Corp. cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income from consolidated operations
$384.7M
$404.5M
—
—
Depreciation and amortization
$104.0M
$94.7M
$93.3M
$96.6M
Gain on disposal of assets
($2.9M)
($1.3M)
($355.5K)
($70.7K)
Loss on disposal of assets
$25.8K
$90.1K
$443.4K
$28.4K
Gain on sale of investments and equity method investment income
($3.4M)
($5.4M)
($5.5M)
($392.0K)
Loss on sale of investments and equity method investment losses
$7.8M
$10.0M
$11.5M
$2.1M
Provision for credit losses
$7.4M
—
—
—
Remeasurement of earnout provision
$2.6M
—
—
—
Deferred income taxes
($18.4M)
($12.4M)
($17.7M)
($17.8M)
Stock based compensation expense related to employee stock options, employee stock purchases and restricted stock
$36.6M
$39.5M
$39.2M
$30.2M
Impairment charges - investments
$14.1M
—
—
—
Impairment charges - goodwill and intangible assets
$0
—
—
—
Accounts receivable
($14.6M)
$27.1M
($45.3M)
($26.7M)
Inventories
$18.1M
($32.6M)
$2.1M
($88.1M)
Prepaid expenses and other
$214.6K
($9.9M)
($4.1M)
($28.8M)
Accounts payable
$52.4M
($26.0M)
$41.0M
$37.4M
Accrued liabilities
($1.7M)
$1.0M
($5.7M)
$14.9M
Net cash flows provided by operating activities
$587.1M
$498.2M
$537.2M
$338.2M
Sales proceeds
$74.0M
$42.7M
$58.8M
$37.4M
Maturities and calls
$2.9M
$16.2M
$17.4M
$3.5M
Purchases
($26.0M)
($51.1M)
($97.8M)
($30.1M)
VOXX share purchases
$0
($31.4M)
—
—
Purchase of technology investments
($22.7M)
($27.7M)
($71.1M)
—
Plant and equipment additions
($129.1M)
($144.7M)
($183.7M)
($146.4M)
Proceeds from sale of plant and equipment
$8.4M
$3.3M
$292.7K
$313.9K
Acquisition of businesses, net of cash acquired
($156.3M)
($2.9M)
($18.9M)
$0
Loans to technology investment partners
($16.2M)
—
—
—
Increase in other assets
($1.9M)
($6.6M)
($4.5M)
($3.6M)
Net cash used for investing activities
($266.9M)
($202.1M)
($299.4M)
($172.7M)
Issuance of common stock from stock plan transactions
$14.5M
$27.3M
$29.4M
$16.6M
Cash dividends paid
($106.9M)
($110.4M)
($112.2M)
($113.1M)
Repurchases of common stock
($315.5M)
($206.1M)
($147.4M)
($112.5M)
Net cash used for financing activities
($407.9M)
($289.3M)
($230.2M)
($209.0M)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
($87.7M)
$6.9M
$7.7M
($43.6M)
CASH AND CASH EQUIVALENTS, Beginning of year
$233.3M
$226.4M
$218.8M
$262.3M
CASH AND CASH EQUIVALENTS, End of year
$145.6M
—
—
—
Change in Property and equipment in accounts payable and accrued expenses and other current liabilities
$17.4M
($9.8M)
$6.9M
—
Gentex Corp. cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income from consolidated operations
$212.6M
$98.4M
$291.4M
$190.5M
Depreciation and amortization
$51.4M
$25.7M
$78.8M
$52.9M
Gain on disposal of assets
($1.9M)
($18.4K)
($161.5K)
($133.6K)
Loss on disposal of assets
$14.7K
$7.5K
$13.2K
$791
Gain on sale of investments and technology investment income
($2.0M)
($1.1M)
($1.6M)
($832.0K)
Loss on sale of investments and technology investment losses
$4.8M
$3.7M
$6.6M
$5.2M
Reserve for credit losses
$5.1M
$2.2M
$4.8M
—
Deferred income taxes
($7.0M)
($3.9M)
($5.8M)
($5.6M)
Stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock
$20.1M
$10.4M
$26.6M
$16.2M
Impairment charges - intangible assets
$2.8M
$2.8M
—
—
Impairment charges - investments
$12.2M
$2.7M
$8.4M
$6.2M
Accounts receivable, net
($17.8M)
($51.0M)
($30.8M)
($20.9M)
Inventories
($2.7M)
($7.3M)
$35.1M
$57.5M
Prepaid expenses and other
$23.0M
$6.0M
($6.4M)
$2.8M
Accounts payable
($1.9M)
$21.1M
$52.6M
$5.0M
Accrued liabilities, excluding dividends declared
$22.9M
$27.4M
$2.0M
$5.9M
Net cash provided by operating activities
$321.7M
$137.1M
$461.6M
$314.6M
Sales proceeds
$1.9M
$492.5K
$71.9M
$48.8M
Maturities and calls
$1.0M
—
$1.7M
$1.7M
Purchases
($3.6M)
($3.1M)
($16.3M)
($17.3M)
Purchase of equity method investments
($4.0M)
($5.5M)
—
—
Plant and equipment additions
($36.2M)
($17.0M)
($103.4M)
($67.8M)
Proceeds from sale of plant and equipment
$442.2K
$70.3K
$259.1K
$245.1K
Acquisition of businesses, net of cash acquired
$0
—
($156.3M)
($143.3M)
Loans to technology investment partners
($4.9M)
($1.3M)
($14.2M)
—
Decrease (increase) in other assets
($3.1M)
$877.3K
($925.4K)
($3.6M)
Net cash used for investing activities
($48.6M)
($25.6M)
($217.3M)
($181.4M)
Issuance of common stock from stock plan transactions
$4.0M
$2.1M
$13.3M
$6.3M
Cash dividends paid
($51.4M)
($25.9M)
($80.6M)
($54.2M)
Repurchases of common stock
($137.9M)
($68.6M)
($229.0M)
($198.9M)
Net cash used for financing activities
($185.3M)
($92.4M)
($296.3M)
($246.8M)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
$87.8M
$19.1M
($51.9M)
($113.5M)
CASH AND CASH EQUIVALENTS, beginning of period
$145.6M
$145.6M
$233.3M
$233.3M
CASH AND CASH EQUIVALENTS, end of period
$233.4M
$164.8M
—
$119.8M
Change in property and equipment in accounts payable and accrued expenses and other current liabilities